Empirical Research on Attitudes Toward Cognitive Enhancement Is Essential to Inform Policy and Practice Guidelines

AJOB Primary Research

Volumn 3, Issue 1, 2012, Pages 58-60

  Lucke, Jayne C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857214289     PISSN: 21507716     EISSN: 21507724     Source Type: Journal    
DOI: 10.1080/21507716.2011.645268     Document Type: Editorial

References (8)

1. Festinger, L. 1957. A theory of cognitive dissonance, Stanford, CA: Stanford University Press.
2. Forlini, C. and Racine, E. 2009. Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics, 10: 9
3. Forlini, C. and Racine, E. Added stakeholders, added value(s) to the cognitive enhancement debate: Are academic discourse and professional policies sidestepping values of stakeholders?. AJOB Primary Research, 3(1)2012-47. 33
4. Franke, A. G., Bonertz, C.Christmann, M. 2011. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44(2): 60-66.
5. Franke, A. G., Bonertz, C., Christmann, M., Engeser, S. and Lieb, K. Attitudes toward cognitive enhancement in users and nonusers of stimulants for cognitive enhancement: A pilot study. AJOB Primary Research, 3(1)2012-57. 48
6. Judson, R. and Langdon, S. W. 2009. Illicit use of prescription stimulants among college students: Prescription status, motives, theory of planned behaviour, knowledge and self-diagnostic tendencies. Psychology, Health & Medicine, 14(1): 97-104.
7. Lucke, J. C., Bell, S., Partridge, B. and Hall, W. D. 2011. Deflating the neuroenhancement bubble. AJOB Neuroscience, 2(4): 38-43.
8. Peretti-Watel, P. 2006. Cognitive dissonance and risk denial: The case of cannabis use in adolescents. Journal of Socio-Economics, 35: 1032-1049.